OptimizeRx Corp — Director's Dealing 2013

Oct 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX.OB)
CIK: 0001448431
Period of Report: 2013-09-20

Reporting Person: Stastney Shadron L. (Former CEO, Chairman, Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-20	Common Stock	A	250000	—	Acquired	250000	Direct